September 16, 2025Circulation Cardiovascular Interventions
Current Concepts in Revascularization for Ischemic Heart Disease With Reduced Ejection Fraction
Authors
Discussion
Loading...
Member takes
Implication
Current review explores revascularization's impact on outcomes in ischemic heart disease, emphasizing ischemic cardiomyopathy.
Key Points
- Revascularization may not improve outcomes in ischemic heart disease with reduced ejection fraction, raising questions.
- The REVIVED-BCIS2 trial showed no benefit of percutaneous coronary intervention on hospitalization or mortality.
- Guidelines on revascularization largely derive from the earlier STICH trial, which does not reflect recent advancements.
- Outstanding questions about the optimal approach to revascularization continue in the management of ischemic cardiomyopathy.
Cite This Study
Mosarla et al. (2025) studied this question.